Monday, July 20, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Approved programs Pipeline Programs

ClinicalTrials.gov programs marked approved or launched in registry data.

Programs 40
Sponsors 800
Drugs 4,222

Quick answer

NovaPharmaNews tracks 40 approved programs pharmaceutical pipeline programs from ClinicalTrials.gov. ClinicalTrials.gov programs marked approved or launched in registry data.

Top sponsors

Pipeline programs

  1. AA-HPP-407

    Alexion Europe SAS

    HYPOPHOSPHATASIA

    approved small molecule active

    1 trial

  2. AL (Coartem)

    United Therapeutics Europe Ltd

    Malaria

    approved small molecule completed

    1 trial

  3. ANGELO

    The George Institute

    Obesity

    approved small molecule active

    1 trial

  4. Alirocumab

    Regeneron UK Limited

    Dyslipidemia

    approved small molecule completed

    1 trial

  5. Amodiaquine plus Artesunate co-administration

    United Therapeutics Europe Ltd

    Malaria

    approved small molecule completed

    1 trial

  6. Aripiprazole

    Otsuka Beijing Research Institute

    Schizophrenia

    approved small molecule completed

    3 trials

  7. Berberine plus lifestyle intervention

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Obesity

    approved small molecule completed

    1 trial

  8. Brentuximab vedotin

    Takeda

    Lymphoma

    approved small molecule active

    2 trials

  9. Candesartan and Hydrochlorothiazide

    Takeda

    Obesity

    approved small molecule completed

    1 trial

  10. Clozapine

    BRIGHT MINDS BIOSCIENCES INC.

    Schizophrenia

    approved small molecule completed

    1 trial

  11. Coartem™ (Artemether-lumefantrine combination)

    United Therapeutics Europe Ltd

    Malaria

    approved small molecule completed

    1 trial

  12. Dynepo

    Takeda

    Anemia

    approved small molecule terminated

    1 trial

  13. ESOMEPRAZOLE, ESOMEPRAZOLE

    Fondazione Telethon ETS

    obesity

    approved small molecule active

    1 trial

  14. EVOLOCUMAB

    Amgen

    Dyslipidemia

    approved small molecule active

    1 trial

  15. EXPAREL

    Pacira Ireland Limited

    Obesity

    approved small molecule completed

    1 trial

  16. Ferric carboxymaltose

    United Therapeutics Europe Ltd

    Anemia

    approved small molecule completed

    1 trial

  17. GTM-103

    GT Biopharma

    Glioblastoma

    approved other active

    1 trial

  18. Iloperidone

    Vanda Pharmaceuticals Netherlands B.V.

    Schizophrenia

    approved small molecule active

    5 trials

  19. Intravenous Ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Obesity

    approved small molecule completed

    1 trial

  20. Lanreotide Autogel 120 mg

    Ipsen

    Acromegaly

    approved small molecule completed

    1 trial

  21. Mifepristone 300 MG [Korlym]

    CORCEPT THERAPEUTICS INC

    Hypercortisolism

    approved small molecule completed

    1 trial

  22. Minocycline

    BRIGHT MINDS BIOSCIENCES INC.

    Schizophrenia

    approved small molecule completed

    1 trial

  23. NN9536-7752

    NovoThirteen

    Obesity

    approved small molecule active

    1 trial

  24. PERSERIS

    Indivior Pty Ltd

    Schizophrenia

    approved small molecule completed

    1 trial

  25. Paliperidone ER

    Hospital Authority, Hong Kong

    Schizophrenia

    approved small molecule completed

    1 trial

  26. Pioglitazone

    Takeda

    Obesity

    approved small molecule completed

    1 trial

  27. Ramelteon

    Takeda

    Schizophrenia

    approved small molecule completed

    1 trial

  28. Semaglutide

    United Therapeutics Europe Ltd

    Obesity

    approved small molecule terminated

    1 trial

  29. Semaglutide B 3.0 mg/ml PDS290

    Disc Medicine

    obesity

    approved small molecule active

    1 trial

  30. Simvastatin

    Hospital Authority, Hong Kong

    Obesity

    approved small molecule active

    1 trial

  31. Skin stretching device (SSD)

    The First People's Hospital of Lianyungang

    Trauma

    approved other active

    1 trial

  32. Stereotactic Radiation Therapy

    GT Biopharma

    Glioblastoma

    approved other terminated

    1 trial

  33. TPO

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    ITP

    approved small molecule completed

    1 trial

  34. Ursodeoxycholic acid combined with total glucosides of paeony

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis

    approved small molecule active

    1 trial

  35. Valbenazine

    NEUROCRINE BIOSCIENCES INC

    Schizophrenia

    approved small molecule active

    3 trials

  36. Varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Schizophrenia

    approved small molecule completed

    2 trials

  37. Vortioxetine

    Takeda

    Schizophrenia

    approved small molecule active

    1 trial

  38. epoetin beta [NeoRecormon]

    Hoffmann-La Roche

    Anemia

    approved small molecule terminated

    1 trial

  39. iron and zinc combined

    United Therapeutics Europe Ltd

    Anemia

    approved other completed

    1 trial

  40. methoxy polyethylene glycol-epoetin beta [Mircera]

    Hoffmann-La Roche

    Anemia

    approved small molecule terminated

    2 trials

Frequently asked questions

How many Approved programs pipeline programs are in the directory?

40 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.